已收盤 04-02 16:00:00 美东时间
0.000
0.00%
SHL Telemedicine (NASDAQ:SHLT) appointed Mr. David Arnon as CEO of the company, effective August 6, 2024. He will succeed Erez Nachtomy, who will step down as CEO. David Arnon joins SHL (SHLT) from Do...
2024-07-29 17:38
Advanced personal telemedicine solutions provider SHL Telemedicine (NASDAQ:SHLT) gained 6.80% on Thursday during pre-market trade as it confirmed discussions with Discount Capital- the investment arm ...
2024-06-20 19:20
12月31日,Shl Telemedicine Limited(SHLT.US)公布财报,公告显示公司2023财年净利润为-7.04百万美元,同比减少9199...
2024-04-19 15:03
SHL Telemedicine press release (NASDAQ:SHLT): FY Net loss was $6.9m, compared to a net loss of $0.4M in FY2022. Revenue of $57.1M (+3.1% Y/Y). Adjusted EBITDA for the company was $2.1M, compared to $...
2024-04-17 17:18
Gainers Longeveron (NASDAQ:LGVN) shares moved upwards by 75.0% to $3.85 during...
2024-04-08 20:10
SHL Telemedicine Ltd. (NASDAQ:SHLT, SIX: SHLTN, )))) ("SHL" or the "Company"), a leading provider and developer of advanced personal telemedicine solutions is pleased to share that in a remarkable
2024-04-08 15:04
Making Significant Investments in Infrastructure and Technology, SHL Telemedicine Advances its US Direct-to-Consumer Strategy Post Positive Initial Trial Results
2023-10-23 14:16
SHL Telemedicine (NASDAQ:SHLT) reported quarterly losses of $(0.25) per share. This is a 316.67 percent decrease over losses of $(0.06) per share from the same period last year. The company reported $29.00 million in
2023-09-21 19:21
TEL AVIV, Israel, ZURICH and NEW YORK, Sept. 6, 2023 /PRNewswire/ -- SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN) (NASDAQ: SHLT) ("SHL" or the "Company"), a leading provider and develo...
2023-09-06 20:00
Gainers Pasithea Therapeutics (NASDAQ:KTTA) stock moved upwards by 11.8% to $0...
2023-07-05 05:37